The growing interest in copyright cannabis strains, specifically those containing compounds like psilocybin or ayahuasca analogs, is fueling a possible new frontier within the medical landscape. Scientists are starting to investigate the therapeutic advantages of these novel cannabis varieties for ailments such as depression , although significant